Market News & Trends
Future of Pharmaceutical R&D Requires Innovative Dosage Formulations
A survey of 500 pharmaceutical industry influencers reveals that four out of five surveyed (82%) believe innovative dosage form technologies are required to meet the…
Pharmacyclics Inks Agreement With Novo Nordisk
Pharmacyclics Inc. recently announced it has signed an agreement with Novo Nordisk A/S giving the Danish insulin producer rights to certain uses of its Factor…
10/16/2012
Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking technology developed…
10/10/2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company and Bioprocess Capital Ventures, recently…
4P Therapeutics Announces Major Development Partnership
4P Therapeutics, a drug delivery company with expertise in novel drug delivery technologies, recently announced a partnership with Medicure Inc. for the development of a…
Bend Research & Dow Chemical to Develop Drug-Solubility Solutions & New Polymers
Bend Research Inc. and The Dow Chemical Company have formed an exclusive collaboration to provide science-based spray-dried dispersion (SDD) solutions and select enabling new polymers…
Catalent Strikes Agreement With Vivus
Catalent Pharma Solutions recently announced it has entered into a Supply Agreement with VIVUS, Inc. to supply Qsymia capsules, a proprietary combination phentermine and extended-release…
Cleveland BioLabs & Incuron Announce Orphan Drug Status
Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company and Bioprocess Capital Ventures, recently announced that curaxin CBL0102 (quinacrine) has been granted…
Mayne Pharma Announces Major Acquisition
Mayne Pharma Group Limited recently announce it has entered into a binding agreement to acquire Metrics, Inc. Consideration for the acquisition will comprise an up-front…
Patheon Launches Innovative Meet the Experts Program
Patheon Inc. recently announced the launch of its new Meet the Experts program. The program provides direct access to scientific and technical experts, both from…
Covidien's Mallinckrodt to Acquire Company for $100 Million
Mallinckrodt, the Pharmaceuticals business of Covidien, recently announced a definitive agreement to acquire CNS Therapeutics, Inc. Mallinckrodt will acquire all of the outstanding capital stock…
Hovione Expands Offering to Solve Bioavailability & Other Delivery Challenges
Hovione recently announced the expansion of its solutions to solve issues of poor bioavailability, patient acceptability, and the enabling of optimal delivery for non-oral routes…
Kinexum & Pennington Biomedical Announce Collaboration
Kinexum and Pennington Biomedical Research Center recently announced plans to establish an integrated approach for emerging companies and early stage therapies to achieve high-value regulatory…
Theorem Clinical Research Expands Service Area Worldwide
To help bring life-saving drugs to market around the world, Theorem Clinical Research Inc. offers Theorem Strategic Sourcing Solutions to provide staffing and outsourcing services…
10/3/2012
Actinium Announces Multi-Million Financing Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a new round of fundraising that…
Actinium Announces Multi-Million Financing
Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a new round of fundraising that will culminate in a…
Clinipace Worldwide Buys Paragon Biomedical; Plans New Hires
Clinipace Worldwide and Paragon Biomedical, Inc. recently announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of the privately held,…
9/25/2012
BD Introduces Shortest, Thinnest Pen Needle Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to…
BD Introduces Shortest, Thinnest Pen Needle
Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that…
Catalent Completes $350-Million Offering
Catalent Pharma Solutions, Inc. recently announced the successful completion of its $350-million offering of 7.875% Senior Notes due 2018, issued at par. Catalent has used…
